AlphaStar Capital Management’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-36,707
Closed -$968K 206
2020
Q2
$968K Sell
36,707
-8,529
-19% -$194K 0.21% 89
2020
Q1
$951K Buy
45,236
+20,469
+83% +$512K 0.22% 84
2019
Q4
$678K Buy
24,767
+1,369
+6% +$36.1K 0.15% 106
2019
Q3
$588K Sell
23,398
-28,895
-55% -$735K 0.14% 109
2019
Q2
$1.37M Sell
52,293
-14,494
-22% -$375K 0.35% 55
2019
Q1
$1.41M Buy
66,787
+38,590
+137% +$978K 0.4% 57
2018
Q4
$663K Sell
28,197
-2,465
-8% -$59.7K 0.21% 90
2018
Q3
$788K Sell
30,662
-5,986
-16% -$155K 0.23% 88
2018
Q2
$949K Buy
36,648
+10,342
+39% +$284K 0.3% 79
2018
Q1
$755K Sell
26,306
-5,280
-17% -$155K 0.29% 82
2017
Q4
$1.04M Buy
31,586
+6,301
+25% +$174K 0.27% 76
2017
Q3
$658K Buy
25,285
+24,909
+6,625% +$659K 0.65% 33
2017
Q2
$9K Buy
+376
New +$9.24K 1.09% 20

Other funds holding SCHE

AlphaStar Capital Management's SCHE Position: Q3 2020 in Review

AlphaStar Capital Management sold out of Schwab Emerging Markets Equity ETF (SCHE) in Q3 2020, closing a stake of 36,707 shares — an estimated $968K sold.

AlphaStar Capital Management first reported a position in SCHE in Q2 2017 and held it in 13 quarters. The position peaked at $1.41M in Q1 2019. 584 funds tracked by Wall St. Rank hold SCHE as of Q3 2020.

  • AlphaStar Capital Management reported no remaining Schwab Emerging Markets Equity ETF position as of Q3 2020 after selling out during the quarter.
  • AlphaStar Capital Management sold 36,707 Schwab Emerging Markets Equity ETF shares in Q3 2020, an estimated $968K.
  • AlphaStar Capital Management first reported a position in Schwab Emerging Markets Equity ETF in Q2 2017 and held it in 13 quarters.
  • AlphaStar Capital Management's Schwab Emerging Markets Equity ETF position peaked at $1.41M in Q1 2019.
  • 584 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q3 2020.

Based on AlphaStar Capital Management's 13F filing for Q3 2020, filed 28 Oct 2020.